Glenmark Life Sciences Limited IPO Price, Detail, Opening Date and More

Glenmark Life Sciences Limited IPO Price, Detail, Opening Date, Allotment Date, Listing Date, Company profile, Financial Report, Owner, BSE, NSE and More

Glenmark Life Sciences Limited is an Indian multinational pharma company. The company headquarter is in Mumbai, Maharashtra, India. It is a leading developer and manufacturer of Active Pharmaceutical Ingredients (APIs).

Glenmark Life Sciences Limited manufactures medicines and vaccines for the customers. The company providing world-class quality and affordable medicines to the patients.

Establishment

Glenmark Life Sciences Limited established in 2011. It develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.

What is Glenmark Life Sciences IPO?

Glenmark Life Sciences Limited Initial public offering (IPO) is a main-board IPO of equity shares of the face value of ₹2 aggregating up to ₹1,513.60 Crores. The issue is priced at ₹695 to ₹720 per equity share. The minimum order quantity is 20 Shares.

Glenmark Life Sciences IPO Details and Tentative Timetable

PointsInformation
IPO Opening DateJul 27, 2021
IPO Closing DateJul 29, 2021
Issue TypeBook Built Issue IPO
Face Value₹2 per equity share
IPO Price₹695 to ₹720 per equity share
Market Lot 20 Shares
Min Order Quantity20 Shares
Listing AtBSE, NSE
Issue Size[.] Eq Shares of ₹2
(aggregating up to ₹1,513.60 Cr)
Fresh Issue[.] Eq Shares of ₹2
(aggregating up to ₹1,060.00 Cr)
Offer for Sale6,300,000 Eq Shares of ₹2
(aggregating up to ₹453.60 Cr)
Basis of Allotment DateAug 3, 2021
Initiation of RefundsAug 4, 2021
Credit of Shares to Demat AccountAug 5, 2021
IPO Listing DateAug 6, 2021

Glenmark Life Sciences IPO Lot Size

The Glenmark Life Sciences IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹187,200).

Company Financials

ParticularsFor the year/period ended (₹ in million)
31-Mar-2131-Mar-2031-Mar-19
Total Assets19,970.7517,256.0414,753.95
Total Revenue18,859.7615,493.038,868.65
Profit After Tax3,515.813,130.981,955.92

Subscription Status

Bid Details for GLS as on 27-Jul-2021 11:30 IST

Sr. NoCategoryNo of Shares
offered/Reserved
No of shares bid forNo of times Subscribed
1Qualified Institutional Buyers(QIBs)42,42,3796,9000.00
1(a)Foreign Institutional Investors(FIIs)0
1(b)Domestic Financial Institutions(Banks/ Financial Institutions(FIs)/ Insurance Companies)0
1(c)Mutual funds0
1(d)Others6,900
2Non Institutional Investors32,32,7702,19,3200.07
2(a)Corporates0
2(b)Individuals(Other than RIIs)2,19,320
2(c)others0
3Retail Individual Investors(RIIs)75,43,1301,03,65,8601.37
3(a)Cut Off82,10,400
3(b)Price bids21,55,460
Total1,50,18,2791,05,92,0800.71

Company Address

Address: Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213, Mumbai, India

Phone: +91 2189 234456/ +91 2189
Email:
complianceofficer@glenmarklifesciences.com
Website:
www.glenmarklifesciences.com

If you want to know anything else about the Glenmark Life Sciences Limited IPO. Please comment below we will try to provide information.

You May Like

Mamaearth Company Profile, Wiki, Products, Discount Offers, Founder, E shopping and more

Netflix Company Profile, Wiki, Owner, Services, Net Worth, Streaming Media and more

Leave a Comment

Exit mobile version